Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

326 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy.
Câmara-Costa H, Resch A, Kieffer V, Lalande C, Poggi G, Kennedy C, Bull K, Calaminus G, Grill J, Doz F, Rutkowski S, Massimino M, Kortmann RD, Lannering B, Dellatolas G, Chevignard M; Quality of Survival Working Group of the Brain Tumour Group of SIOP-Europe. Câmara-Costa H, et al. Among authors: doz f. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):978-985. doi: 10.1016/j.ijrobp.2015.04.023. Epub 2015 Apr 17. Int J Radiat Oncol Biol Phys. 2015. PMID: 26194675 Free article. Clinical Trial.
Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP).
Carrie C, Hoffstetter S, Gomez F, Moncho V, Doz F, Alapetite C, Murraciole X, Maire JP, Benhassel M, Chapet S, Quetin P, Kolodie H, Lagrange JL, Cuillere JC, Habrand JL. Carrie C, et al. Among authors: doz f. Int J Radiat Oncol Biol Phys. 1999 Sep 1;45(2):435-9. doi: 10.1016/s0360-3016(99)00200-x. Int J Radiat Oncol Biol Phys. 1999. PMID: 10487567
Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.
Grill J, Le Deley MC, Gambarelli D, Raquin MA, Couanet D, Pierre-Kahn A, Habrand JL, Doz F, Frappaz D, Gentet JC, Edan C, Chastagner P, Kalifa C; French Society of Pediatric Oncology. Grill J, et al. Among authors: doz f. J Clin Oncol. 2001 Mar 1;19(5):1288-96. doi: 10.1200/JCO.2001.19.5.1288. J Clin Oncol. 2001. PMID: 11230470 Clinical Trial.
Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology.
Laithier V, Grill J, Le Deley MC, Ruchoux MM, Couanet D, Doz F, Pichon F, Rubie H, Frappaz D, Vannier JP, Babin-Boilletot A, Sariban E, Chastagner P, Zerah M, Raquin MA, Hartmann O, Kalifa C; French Society of Pediatric Oncology. Laithier V, et al. Among authors: doz f. J Clin Oncol. 2003 Dec 15;21(24):4572-8. doi: 10.1200/JCO.2003.03.043. J Clin Oncol. 2003. PMID: 14673044
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.
Oyharcabal-Bourden V, Kalifa C, Gentet JC, Frappaz D, Edan C, Chastagner P, Sariban E, Pagnier A, Babin A, Pichon F, Neuenschwander S, Vinchon M, Bours D, Mosseri V, Le Gales C, Ruchoux M, Carrie C, Doz F. Oyharcabal-Bourden V, et al. Among authors: doz f. J Clin Oncol. 2005 Jul 20;23(21):4726-34. doi: 10.1200/JCO.2005.00.760. J Clin Oncol. 2005. PMID: 16034048
Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children.
Grill J, Sainte-Rose C, Jouvet A, Gentet JC, Lejars O, Frappaz D, Doz F, Rialland X, Pichon F, Bertozzi AI, Chastagner P, Couanet D, Habrand JL, Raquin MA, Le Deley MC, Kalifa C; French Society of Paediatric Oncology. Grill J, et al. Among authors: doz f. Lancet Oncol. 2005 Aug;6(8):573-80. doi: 10.1016/S1470-2045(05)70252-7. Lancet Oncol. 2005. PMID: 16054568 Clinical Trial.
326 results